KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Net Margin (2016 - 2025)

Historic Net Margin for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to 5.62%.

  • Evolent Health's Net Margin fell 5900.0% to 5.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.81%, marking a year-over-year decrease of 45800.0%. This contributed to the annual value of 3.66% for FY2024, which is 35900.0% up from last year.
  • As of Q3 2025, Evolent Health's Net Margin stood at 5.62%, which was down 5900.0% from 11.5% recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Net Margin peaked at 0.6% during Q3 2022, and registered a low of 14.94% during Q1 2025.
  • For the 5-year period, Evolent Health's Net Margin averaged around 5.16%, with its median value being 4.74% (2024).
  • In the last 5 years, Evolent Health's Net Margin skyrocketed by 895600bps in 2021 and then crashed by -109900bps in 2025.
  • Over the past 5 years, Evolent Health's Net Margin (Quarter) stood at 2.27% in 2021, then plummeted by -31bps to 2.97% in 2022, then tumbled by -151bps to 7.44% in 2023, then soared by 36bps to 4.74% in 2024, then dropped by -19bps to 5.62% in 2025.
  • Its last three reported values are 5.62% in Q3 2025, 11.5% for Q2 2025, and 14.94% during Q1 2025.